APAC Healthcare Weekly (Oct 20)- Eisai, Daiichi Sankyo, Junshi Bioscience, Akeso, Celltrion, Neuren
This insight collates key news in APAC healthcare last week. With the earnings season beginning to unfold along with major pharma and healthcare...
498 Views
Akeso Biopharma Placement - The Placing Price Is Not Cheap Despite Positive Business Progress
​Akeso delivers impressive HARMONi-2 data, which greatly increases the possibility of positive OS. But the market cap already partially reflects...
727 Views
ECM Weekly (14th Oct 2024) - Tokyo Metro, Rigaku, Hyundai, China Res, Swiggy, USS, Akeso, Shiyue
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
663 Views
China Healthcare Weekly (Oct.13)-Genor to Acquire Edding, RemeGen's Bleak Outlook, Zai Lab's Trouble
Genor/Edding are merging through a reverse takeover, but valuation is unsatisfactory. Remegen is negative example among China Biotech.Weak...
715 Views
Akeso Placement - Opportunistic Raise, past Deal Record Has Been Mixed but Relative Size Is Small
Akeso Biopharma Inc (9926 HK) is looking to raise around US$200m from its primary placement. Proceeds from the placement will be used for R&D.
696 Views